Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 23:3:2398212818810682.
doi: 10.1177/2398212818810682. eCollection 2019 Jan-Dec.

Catecholamines: Knowledge and understanding in the 1960s, now, and in the future

S Clare Stanford  1 , David J Heal  2
Affiliations
Review

Catecholamines: Knowledge and understanding in the 1960s, now, and in the future

S Clare Stanford et al. Brain Neurosci Adv. .

Abstract

The late 1960s was a heyday for catecholamine research. Technological developments made it feasible to study the regulation of sympathetic neuronal transmission and to map the distribution of noradrenaline and dopamine in the brain. At last, it was possible to explain the mechanism of action of some important drugs that had been used in the clinic for more than a decade (e.g. the first generation of antidepressants) and to contemplate the rational development of new treatments (e.g. l-dihydroxyphenylalanine therapy, to compensate for the dopaminergic neuropathy in Parkinson's disease, and β1-adrenoceptor antagonists as antihypertensives). The fact that drug targeting noradrenergic and/or dopaminergic transmission are still the first-line treatments for many psychiatric disorders (e.g. depression, schizophrenia, and attention deficit hyperactivity disorder) is a testament to the importance of these neurotransmitters and the research that has helped us to understand the regulation of their function. This article celebrates some of the highlights of research at that time, pays tribute to some of the subsequent landmark studies, and appraises the options for where it could go next.

Keywords: catecholamine; dopamine; drug development; noradrenaline.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Anden NE, Carlsson A, Dahlstroem A, et al. (1962) Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sciences 3(6): 523–530. - PubMed
    1. Anderzhanova E, Wotjak CT. (2013) Brain microdialysis and its applications in experimental neurochemistry. Cell and Tissue Research 354(1): 27–39. - PubMed
    1. Angelides KJ. (1980) Transport of catecholamines by native and reconstituted rat heart synaptic vesicles. Journal of Neurochemistry 35(4): 949–962. - PubMed
    1. Axelrod J, Laroche MJ. (1959) Inhibitor of O-methylation of epinephrine and norepinephrine in vitro and in vivo. Science 130(3378): 800. - PubMed
    1. Axelrod J, Whitby LG, Hertting G. (1961) Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science 133(3450): 383–384. - PubMed

LinkOut - more resources